CS Paper Radar

An Evidence-Driven Multi-Agent Compound AI System for Head and Neck Proton Radiotherapy Planning

Qingqing Wang, Liqiang Xiao, Chang Chang

cs.AI ·submitted 2026-10-21 00:21 UTC · v1

Abstract

Radiation treatment planning requires balancing competing objectives to satisfy clinical criteria while accommodating physicians' preferences. This study aims to develop an evidence-driven, multi-agent compound AI system that integrates DRL-based automated treatment planning with LLM-based conversational plan refinement for proton PBS therapy. A policy network trained using PPO first generates multiple plans without human intervention, from which one is selected as the target plan and the others serve as references for subsequent refinements. For challenging cases requiring further adjustments, an LLM-based multi-agent system enables plan refinement through natural language interactions. The system comprises a planning agent that recommends evidence-supported adjustments, a chatbot providing a unified conversational interface, and an evaluation agent that retrieves clinical metrics and identifies constraint violations. To enhance domain-specific reasoning, the planning agent based on Qwen3-14B is designed to justify its recommendations using evidence from previously generated plans and post-trained on task-specific data using SFT and GRPO. The framework was trained and evaluated using 21 patients with H&N cancers, with 5 PPO-generated plans per patient. Of these, 50 plans were selected for instruction-guided refinement. Compared with the base LLM, the post-trained Qwen3-14B demonstrated improved instruction-following, information retrieval and domain-specific reasoning capabilities. The resulting adjustments more effectively improved user-prioritized objectives while limiting deterioration in competing objectives, yielding more clinically appropriate trade-offs in patient-specific plan refinement. The proposed compound AI system provides a user-friendly planning platform, offering a promising approach to personalized proton PBS treatment planning.

Closest papers

Nearest neighbours by meaning across the whole index.

An Agentic Generative Large Language Model for Treatment Planning of Colorectal Cancer

cs.CL ·2026-08-10 ·Mengxian Lyu, Cheng Peng, Tim Jang, Ang Li, Mengyuan Zhang +16 more
code/data similarity 0.72
Abstract

Treatment planning in precision oncology requires synthesizing heterogeneous patient information with rapidly evolving clinical guidelines to ensure guideline-concordant care. While large language models (LLMs) show promise in many diagnostic tasks, their adoption for high-stakes treatment planning is hindered by complex reasoning, adherence to timely clinical guidelines, and safety concerns. In this study, we present GatorOnco, an agentic LLM for colorectal cancer (CRC) treatment planning. GatorOnco is developed using a total of 282 billion tokens of biomedical text, including healthcare system-scale clinical text comprising 166 billion tokens from UF Health. We implemented a domain-adaptation method that integrates pre-training, model merging, a two-stage post-training approach, and agent-based reinforcement learning. An agentic retrieval-augmented generation (RAG) approach dynamically integrates time-sensitive clinical guidelines into the reasoning process. In a blind, randomized clinical evaluation conducted by five UF Health oncologists, GatorOnco significantly outperformed open-source LLMs (P < 0.01) and achieved expert-level performance comparable to UF Health oncologists. Compared with expert oncologists, GatorOnco received significantly higher ratings for readability (4.46 vs. 4.19, P < 0.01) and completeness (3.91 vs. 3.52, P < 0.01), while showing statistically comparable performance in correctness (4.09 vs. 4.11, P = 0.921), currency (4.04 vs. 3.98, P = 0.478), and safety (4.22 vs. 4.22, P = 0.999). These findings demonstrate that integrating agentic reasoning with large-scale domain adaptation can help bridge the gap for generative AI in high-stakes cancer treatment planning.

0.50

BioMed-Agent-RL: A Meta Learning, All You Need for Biomedical Applications

cs.LG cs.AIcs.CV ·2026-08-22 ·Md Asaduzzaman Jabin, Zihao Wu, Tianming Liu
hot direction similarity 0.69
Abstract

The current progress of Clinical Vision Large Language Models (C-VLLMs) has substantially improved digital diagnostics, still these frameworks often endure lesion noises, modality misalignment, hallucination, and missed contextual grounding in complex clinical cases. Moreover, prevailing agent systems usually depend on static and non-adaptable pipelines and lack the versatility necessary for complex medical reasoning. To resolve these difficulties, we present BioMed-Agent-RL, a unified medical agent that incorporates adaptive orchestration, policy, and reward-based reinforcement learning (RL) models for biomedical applications. To ensure reliability, it invokes clinical context-aware preference optimization (CPO), direct preference optimization (DPO), and group relative policy optimization (GRPO) with dynamic entropy regulation. This pipeline utilizes a multimodal meta-learning approach that operates as a field-specific expert and human judgment synthesizer. The agent adaptively utilizes a set of model-level expertise, such as clinical grounding and reasoner, lesion segmenter, and field-specific synthesizer, across various clinical modalities (e.g., X-ray) by utilizing an iterative and adaptive RL approach. The agent learns to seriously synthesize misleading, conflicting vision cues and trust in inherent reasoning, while specialist advice is faulty. An intensive ablation study is conducted across multiple benchmarks, and the agent significantly outperforms existing state of the art models, such as GPT-5, attaining up to ~73% accuracy (gain of ~5%) over contemporary baselines. As a result, the framework suggests a new standard for building factual, reliable, robust, and expert-like intelligent agent systems for independent clinical reasoning.

0.23

Evidence, Logic, and Compliance: Multi-Agent Structured Graph Reasoning with Expert Arbitration for Medical Referral

cs.MA ·2026-08-31 ·Qi Peng, Yi Cai, Jialin Cui, Tong Zhu, Yujuan Ding +5 more
similarity 0.67
Abstract · 18 pages

Medical referral (directing patients to the appropriate hospital department) is a complex decision-making process requiring the synthesis of multimodal data, including patient narratives, laboratory indicators, and radiology imaging. While Large Language Models (LLMs) have advanced medical dialogue systems, they struggle with real-world referral tasks due to two primary limitations: (1) Information Overload, where models fixate on high-frequency disease terms while overlooking subtle but critical urgency indicators; and (2) Unstructured Collaboration, where existing multi-agent frameworks rely on loose dialogue that leads to semantic drift and confirmation bias. To address these challenges, we introduce MASGR (Multi-Agent Structured Graph Reasoning), a framework that treats referral not as a classification task but as a structured graph construction problem. MASGR deploys specialized agents to extract evidence from distinct modalities and coordinates them through a clinical reasoning graph. This graph forces agents to establish explicit logical connections between conflicting evidence. Furthermore, we integrate a knowledge-guided arbitration mechanism that prioritizes patient safety rules over standard diagnostic classification. Extensive experiments on real-world medical records demonstrate that MASGR significantly outperforms state-of-the-art LLMs and existing multi-agent systems, particularly in complex cases requiring the balancing of chronic disease management and emergency intervention. The AI contribution lies in the Multi-Agent Structured Graph Reasoning framework that transforms unstructured multi-agent dialogue into a verifiable logical graph construction. The engineering application is demonstrated through its deployment in a complex healthcare decision-making system to optimize the precision of complex medical referrals.

0.17

OpenGray: a benchmark for evaluating the decisions of radiotherapy planning agents

cs.AI physics.med-ph ·2026-10-27 ·Humza Nusrat, Kundan Thind
benchmark similarity 0.67
Abstract · 25 pages, 4 figures, 1 table, and the supplementary material (19 tables, 5 figures). Ancillary files: the paper in Markdown, structured resu…

Background and purpose: Radiotherapy planning agents based on large language models (LLMs) decide when to submit a plan or request review but are evaluated mainly by dose. This study developed OpenGray, a benchmark of planning tasks with known correct decisions. Materials and methods: OpenGray adds tasks with known answers to the OpenKBP-Opt head-and-neck dataset, including two contradictions with dose goals proven incompatible and a feasible control with a stored plan meeting every hard goal. Four systems, from a rule-based planning script to a full LLM agent, were evaluated on 30 patients, the LLM-based ones with a commercial (Terra) and a local (Ministral 3 8B) LLM. Decisions, achieved dose, problem recognition, and technical failures were recorded and also read from logs of 39 stereotactic radiosurgery runs of SAGE, a clinical LLM agent. Results: With Terra, the script preceded by an LLM review and the full agent had decision accuracies of 95.4% and 92.1%, respectively, yet escalated only 50% (95% confidence interval, 25-75%) and 25% (10-40%) of overlap contradictions, which required arithmetic on the anatomy. All four systems submitted every feasible control, but 24% of these plans missed a hard goal that the stored plan had met. In four SAGE runs, one goal failed at every attempt; the agent identified it in every reply but had no action for stopping. Conclusions: Favorable aggregate scores concealed specific decision failures. Planning agents should be evaluated on their decisions as well as their dose and given an explicit action for stopping and requesting review.

0.49

Reinforcement Learning In Partially Verifiable Environments for Colon Cancer Treatment Planning

cs.LG cs.AI ·2026-10-12 ·Li-Ching Chen, Andrés Franco Valiente, Yuta Ishiyama, Zachary R. Chalmers, William Chen +5 more
similarity 0.65
Abstract

Clinical decision-making is a sequential process of information collection, clinical inference, and forecasting under partial observability, often without a uniquely correct treatment decision. Large language models (LLMs) have demonstrated strong medical question-answering capabilities but extending these advances to clinical reasoning remains challenging because many clinical tasks are only partially verifiable. Recent clinical reinforcement learning (RL) work has therefore largely focused on diagnostic endpoints, where correctness can be more directly verified. Oncology treatment decision making is a particularly challenging instance of this problem that extends beyond medical question-answering in which multiple decision trajectories can be clinically defensible for the same partially observed patient state. We formulate oncology treatment planning as an interactive RL problem under partial observability and construct patient-specific, process-aware rewards from decision processes observed in real world clinical records. The agent must learn to sequentially acquire information from a structured patient representation before committing to a first-line treatment recommendation, and is evaluated on information gathering, treatment selection, and reasoning alignment. Using GRPO and GDPO to optimize Llama-3.1-8B-Instruct within this environment, RL substantially improves the base policy beyond frontier model capabilities. The GDPO-trained policy increases Mean@3 scalar clinical reward by $79.60\%$ over base Llama and exceeds GPT-5.2 by $18.82\%$ under the same interactive environment, while reducing query count during training. Overall, our results show that patient-specific, partially verifiable rewards can provide an effective learning signal for interactive clinical RL when both the patient state and the underlying clinical decision process are only partially observed.

0.18

ClinAgent: A ReAct-Based Agent for Conversational Access to Clinical Trial Information

cs.AI cs.CLcs.IR ·2026-09-12 ·Antonino Vaccarella, Riccardo Cantini, Domenico Talia, Paolo Trunfio, Marianna Talia +2 more
published similarity 0.65
Abstract · Accepted at the CIBB 2026 conference (https://cibb2026.teralab.ai/)

Querying clinical trial registries remains a manual and error-prone process, requiring researchers to navigate large volumes of semi-structured data without support for natural language interaction or cross-source synthesis. To address this, we introduce ClinAgent, a conversational system based on agentic Retrieval-Augmented Generation (RAG) that enables clinicians and researchers to query clinical trial information in plain language and receive grounded, up-to-date responses across multi-turn interactions. The system centers on a Large Language Model (LLM) agent following the ReAct paradigm, which iteratively reasons over queries, selects among a set of integrated tools, and refines its actions based on intermediate outputs. These tools include a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on a locally cached structured dataset of clinical trials. We evaluate the system using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments, comparing three LLM backends: Gemini 3.0 Flash and two variants of DeepSeek V3.2 (thinking and non-thinking). Results reveal complementary strengths, with DeepSeek (thinking mode) excelling in planning quality, while Gemini achieves the highest overall performance and strongest expert ratings. Overall, our findings highlight the potential of agentic AI systems to improve the accessibility and synthesis of clinical trial information, supporting more efficient and user-centered biomedical research workflows.

0.29

EMR: Self-Evolving Medical Multi-Agent System via Experience Mining and Reuse

cs.CL cs.AI ·2026-09-14 ·Dongsheng Shi, Yue Li, Xin Yi, Linlin Wang
similarity 0.65
Abstract

Large language model (LLM) driven multi-agent systems have shown promise in complex clinical reasoning, yet existing approaches rely on static strategies and lack persistent clinical memory, preventing self-evolving from prior diagnostic successes and failures. We present EMR, a self-evolving medical multi-agent system via Experience Mining and Reuse. EMR introduces a hierarchical clinical experience library that organizes accumulated knowledge into three levels: clinical principles, diagnostic patterns, and representative cases. During inference, EMR emulates multidisciplinary consultation: a planner agent coordinates domain-specific department agents for specialized reasoning, while a summary agent synthesizes their analyses into a final decision. Critically, EMR automatically extracts correct diagnostic insights and failure-related warnings from multi-agent reasoning trajectories, incrementally updating the experience library to guide future cases. Experiments on medical reasoning benchmarks demonstrate that EMR consistently outperforms state-of-the-art medical multi-agent baselines. Further analysis reveals that the hierarchical experience enables cross-specialty generalization and transfer across diverse LLM backbones, offering a scalable and in

0.26

ClinVerse: A Realistic Multi-Agent Diagnostic Environment for Training and Evaluating Medical Agents

cs.AI cs.MA ·2026-10-26 ·Sirry Chen, Fangke Chen, Xuanwen Ding, Wei Chen, Zhongyu Wei
similarity 0.65
Abstract

Disease diagnosis is a key application of large language model (LLM) agents in healthcare. However, existing medical agents are primarily trained and evaluated with static question-answering data, providing limited opportunities to learn active information acquisition, examination decision-making, and dynamic clinical interaction. To address this limitation, we present ClinVerse, an interactive, real-data-grounded multi-agent environment designed for training and evaluating medical diagnostic agents. Built on ClinPatient, a scalable dataset comprising 150k diagnostic cases derived from real-world electronic health records, ClinVerse supports coordinated interactions among six specialized clinical roles. Specifically, a doctor agent starts from an initial patient complaint, progressively gathers clinical evidence through patient interviews and examination requests, and ultimately produces a diagnosis. For each interaction trajectory, a rule-based scoring framework quantifies information acquisition, examination ordering, and diagnostic accuracy. These trajectory-level scores serve as reward signals for agent training while also enabling scalable evaluation. In experiments, we evaluate various general-purpose and medical-domain models and show that nine self-evolution methods across three categories consistently improve agents' diagnostic capabilities within ClinVerse. We further analyze the interplay among model capability, environment feedback, and self-evolution methods.

0.13